Company Moderna, Inc.

Equities

MRNA

US60770K1079

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 15:12:47 2025-06-20 EDT			5-day change	1st Jan Change
25.64 ^USD	+0.96%		-4.01%	-38.43%

06-18	Kennedy's new US vaccine panel to discuss measles shot for children	RE
06-18	Kennedy's new US vaccine panel to discuss measles shot for children	RE

Business description: Moderna, Inc.

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:

- revenue from product sales (97.4%);

- grant revenue (1.4%);

- revenue from collaboration agreements (1.2%).

At the end of 2023, the group possessed a portfolio of 41 products in clinical development, of which 6 in phase III, 12 in phase II and 18 in phase I, and 5 products in preclinical development.

Net sales are distributed geographically as follows: the United States (27.7%), Europe (19.8%) and other (52.5%).

Number of employees: 5,800

Sales by Activity: Moderna, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
Biotechnology	803M	18.47B	19.26B	6.85B	3.24B

See all business segments

Geographical breakdown of sales: Moderna, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024
United States	765M	6.18B	5.15B	1.9B	1.78B
Rest of World	38.87M	5.45B	7.3B	3.6B	853M
Europe	-	6.85B	6.82B	1.36B	598M

See all geographic segments

Executive Committee: Moderna, Inc.

Manager	Title	Age	Since
Stéphane Bancel CEO	Chief Executive Officer	52	2011-02-28
James Mock DFI	Director of Finance/CFO	48	2022-09-05
Stephen Hoge PSD	President	49	2024-10-31
Jerh Collins CTO	Chief Tech/Sci/R&D Officer	-	2022-12-31
Jacqueline Miller CTO	Chief Tech/Sci/R&D Officer	53	2024-11-06

See MODERNA, INC. governance

Composition of the Board of Directors: Moderna, Inc.

Director	Title	Age	Since
Paul Sagan BRD	Director/Board Member	66	2018-05-31
Noubar Afeyan CHM	Chairman	61	2012-01-31
Stéphane Bancel BRD	Director/Board Member	52	2011-02-28
Francois Nader BRD	Director/Board Member	68	2019-12-10
Sandra Horning BRD	Director/Board Member	76	2020-02-29
Elizabeth Tallett BRD	Director/Board Member	76	2020-06-30
Elizabeth Nabel BRD	Director/Board Member	73	2015-11-30
David Rubenstein BRD	Director/Board Member	75	2024-08-04
Shah Hussain BRD	Director/Board Member	60	2024-10-01

Composition of the Board of Directors

Shareholders: Moderna, Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 10.47 %	40,396,513	10.47 %	1 073 M $
Baillie Gifford & Co. 6.466 %	24,948,558	6.466 %	663 M $
Stéphane Bancel 5.513 %	21,269,463	5.513 %	565 M $
Fidelity Management & Research Co. LLC 5.477 %	21,130,029	5.477 %	561 M $
BlackRock Advisors LLC 5.395 %	20,813,245	5.395 %	553 M $

Name	Equities	%	Valuation
BTG Pactual WM Gestão de Recursos Ltda. 0.000276 %	21,316	0.000276 %	28 523 $

List of MODERNA, INC. shareholders

Holdings: Moderna, Inc.

Name	Equities	%	Valuation
METAGENOMI, INC. 4.56%	1,707,473	4.56%	2,902,704 $
GENERATION BIO CO. 8.77%	5,859,375	8.77%	2,214,844 $
CARISMA THERAPEUTICS, INC. 12.12%	5,059,338	12.12%	966,334 $

Company details: Moderna, Inc.

Moderna, Inc.

325 Binney Street

02142, Cambridge

+617 714 6500

http://www.modernatx.com

Group companies: Moderna, Inc.

Name	Category and Sector
ModernaTX, Inc. ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA.	Biotechnology
Moderna Switzerland GmbH

Name

Category and Sector

Biotechnology

Moderna Switzerland GmbH

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MODERNA, INC.	+0.96%	-4.01%	-80.95%	-80.31%	9.82B
LONZA GROUP AG	+0.39%	-1.51%	+16.56%	+14.23%	48.12B
BEONE MEDICINES LTD.	-2.41%	-8.62%	+58.40%	+61.38%	29.99B
REGENCELL BIOSCIENCE HOLDINGS LIMITED	-44.03%	+128.30%	+33,853.94%	+3,160.99%	31.33B
IQVIA HOLDINGS INC.	+0.08%	-1.51%	-27.86%	-22.26%	26.75B
CELLTRION, INC.	+1.25%	-1.04%	-3.42%	+20.40%	25.65B
EUROFINS SCIENTIFIC SE	+0.10%	-1.36%	+11.76%	-17.45%	12.25B
TEMPUS AI, INC.	-1.46%	-5.20%	+147.87%	-	11.96B
ICON PUBLIC LIMITED COMPANY	+1.70%	+0.12%	-53.85%	-28.95%	11.41B
ASCENDIS PHARMA A/S	+3.52%	+2.75%	+44.30%	+105.26%	10.31B
Average	-4.04%	+26.09%	+3,396.68%	+357.03%	21.76B
Weighted average by Cap.	-6.24%	+38.68%	+4,886.34%	+492.30%